A large number of studies indicate that Potassium Voltage-Gated Channel Q4 (KCNQ4) gene is the cause of non-syndromic hearing loss, but there are few studies investigating the role of KCNQ4 in cancers and scarcity of comprehensive analysis of its involvement in the diagnosis, methylation, mutation, prognosis of various cancer types. Therefore, the aim of this study is to examine the anticancerous and immune effects of KCNQ4 in various cancers and its potential value in breast cancer. In this study, we explored the potential role of KCNQ4 in cancers using public databases and the R software for bioinformatics analysis. The results showed that the low expression of KCNQ4 across specific cancer types was positively associated with low mutation frequency and methylation, and the improved survival. Eight small molecule compounds were identified that could potentially target KCNQ4. In addition, immunohistochemistry confirmed that the KCNQ4 expression was low in breast cancer. In vitro experiments confirmed that overexpression of KCNQ4 inhibited cell migration and invasion and promoted apoptosis. In summary, our comprehensive pan-cancer analysis highlights the potential of KCNQ4 as a cancer marker, and can be used as an auxiliary prognostic indicator and an indicator for immunotherapy in certain tumor types.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616121 | PMC |
| http://dx.doi.org/10.1038/s41598-023-45074-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive pan‑cancer analysis of potassium voltage-gated channel Q4 (KCNQ4) gene across multiple human malignant tumors.
Sci Rep
October 2023
Pathology Department, First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang, China.
A large number of studies indicate that Potassium Voltage-Gated Channel Q4 (KCNQ4) gene is the cause of non-syndromic hearing loss, but there are few studies investigating the role of KCNQ4 in cancers and scarcity of comprehensive analysis of its involvement in the diagnosis, methylation, mutation, prognosis of various cancer types. Therefore, the aim of this study is to examine the anticancerous and immune effects of KCNQ4 in various cancers and its potential value in breast cancer. In this study, we explored the potential role of KCNQ4 in cancers using public databases and the R software for bioinformatics analysis.
View Article and Find Full Text PDFLncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer.
Mol Cancer
March 2023
Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, 250000, China.
Background: Breast cancer is the most common malignant tumor that threatens women's health. Attention has been paid on the study of long- non-coding RNA (lncRNA) in breast cancer. However, the specific mechanism remains not clear.
View Article and Find Full Text PDFProstate Cancer Secretome and Membrane Proteome from Conditional Knockout Mice Identify Potential Biomarkers for Disease Progression.
Int J Mol Sci
August 2022
Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu (IBB), São Paulo State University (UNESP), Botucatu 18618-689, SP, Brazil.
Prostate cancer (PCa) is the second most common cause of mortality among men. Tumor secretome is a promising strategy for understanding the biology of tumor cells and providing markers for disease progression and patient outcomes. Here, transcriptomic-based secretome analysis was performed on the PCa tumor transcriptome of Genetically Engineered Mouse Model (GEMM) mice to identify potentially secreted and membrane proteins-PSPs and PMPs.
View Article and Find Full Text PDFIntegrative analysis of clinical and epigenetic biomarkers of mortality.
Aging Cell
June 2022
The Framingham Heart Study, Framingham, Massachusetts, USA.
Article Synopsis
- DNA methylation (DNAm) has a significant link to various diseases and is a potential factor in predicting mortality, particularly when combined with clinical risk factors.
- In a study involving 15,013 participants over 10 years, researchers identified specific CpGs associated with all-cause mortality, cardiovascular, and cancer death in both European and African ancestry groups.
- The study developed a DNAm-based prediction model that improved cancer death risk prediction, found potential causal relationships between certain CpGs and longevity, and highlighted their relevance in immune and cancer-related pathways.
Cigarette Smoke Directly Promotes Pulmonary Arterial Remodeling and Kv7.4 Channel Dysfunction.
Am J Respir Crit Care Med
May 2021
Biomedical Research Institute La Princesa Hospital, Madrid, Spain.
Cigarette smoke is considered the chief leading cause of chronic obstructive pulmonary disease (COPD). Its impact on the progressive deterioration of airways has been extensively studied, but its direct effects on the pulmonary vasculature are less known. To prove that pulmonary arterial remodeling in patients with COPD is not just a consequence of alveolar hypoxia but also due to the direct effects of cigarette smoke on the pulmonary vascular bed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!